Details
Stereochemistry | ACHIRAL |
Molecular Formula | C14H12O5 |
Molecular Weight | 260.2421 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
COC1=C2OC(C)=CC(=O)C2=C(OC)C3=C1OC=C3
InChI
InChIKey=HSMPDPBYAYSOBC-UHFFFAOYSA-N
InChI=1S/C14H12O5/c1-7-6-9(15)10-11(16-2)8-4-5-18-12(8)14(17-3)13(10)19-7/h4-6H,1-3H3
Khellin is a crystalline extract of a crude drug, which has long been used in Egypt for the treatment of ureteral colic. It is used in the management of bronchial asthma and angina pectoris. Interest in khellin as an adjunct to ultraviolet (UV) light therapy in the treatment of vitiligo is based on the structural similarity between khellin and the psoralens. Success has been reported using oral and topical khellin in clinical studies but it is not likely that khellin will be approved for the treatment of vitiligo. Unwanted side effects of khellin include dizziness, reversible cholestatic jaundice, pseudoallergic reaction, and elevated levels of liver enzymes (transaminases and gamma-glutamyltransferase).
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL2231 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24069365 |
|||
Target ID: CHEMBL3201 Sources: https://www.ncbi.nlm.nih.gov/pubmed/24069365 |
|||
Target ID: Calcium influx Sources: https://www.ncbi.nlm.nih.gov/pubmed/2568462 |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Ammivin Approved UseKhellin is used for Angina pectoris, Asthma, Vitiligo, Ultraviolet irradiation and other conditions. |
|||
Palliative | Ammivin Approved UseKhellin is used for Angina pectoris, Asthma, Vitiligo, Ultraviolet irradiation and other conditions. |
|||
Palliative | Ammivin Approved UseKhellin is used for Angina pectoris, Asthma, Vitiligo, Ultraviolet irradiation and other conditions. |
Overview
CYP3A4 | CYP2C9 | CYP2D6 | hERG |
---|---|---|---|
OverviewOther
Other Inhibitor | Other Substrate | Other Inducer |
---|---|---|
Drug as perpetrator
Target | Modality | Activity | Metabolite | Clinical evidence |
---|---|---|---|---|
no [IC50 >10 uM] | ||||
no [IC50 >10 uM] | ||||
no [IC50 >10 uM] | ||||
no [IC50 >10 uM] | ||||
weak [IC50 34.6 uM] | ||||
yes [IC50 0.04 uM] | ||||
yes [IC50 4.02 uM] | ||||
yes [Inhibition 10 uM] | ||||
yes [Inhibition 10 uM] | ||||
Sources: https://pubmed.ncbi.nlm.nih.gov/24069365/ |
yes |
PubMed
Title | Date | PubMed |
---|---|---|
Cytosolic acidification as a signal mediating hyperosmotic stress responses in Dictyostelium discoideum. | 2001 |
|
Evaluation of the process for superoxide production by NADPH oxidase in human neutrophils: evidence for cytoplasmic origin of superoxide. | 2001 |
|
Coronin from roots of Annona muricata, a putative intermediate in acetogenin biosynthesis (1). | 2001 Aug |
|
Genetic approaches to dissect the mechanisms of two distinct pathways of cell cycle-coupled cytokinesis in Dictyostelium. | 2001 Dec |
|
Coronin forms a stable dimer through its C-terminal coiled coil region: an implicated role in its localization to cell periphery. | 2001 Mar |
|
Role of actin polymerization and actin cables in actin-patch movement in Schizosaccharomyces pombe. | 2001 Mar |
|
An SH2-domain-containing kinase negatively regulates the phosphatidylinositol-3 kinase pathway. | 2001 Mar 15 |
|
Long-term results in the treatment of vitiligo with oral khellin plus UVA. | 2001 May-Jun |
|
Membrane-cytoskeleton interactions during the formation of the immunological synapse and subsequent T-cell activation. | 2002 Nov |
|
Immune evasion by Mycobacterium tuberculosis: living with the enemy. | 2003 Aug |
|
KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in vitro. | 2003 Oct |
|
Vitamin D3-dependent pathway regulates TACO gene transcription. | 2003 Oct 24 |
|
The chemical investigations on the ripe fruits of Ammi visnaga (Lam.) Lamarck growing in Turkey. | 2004 Apr |
|
Coronin-1 expression in T lymphocytes: insights into protein function during T cell development and activation. | 2004 Feb |
|
Cytotoxic activity of five compounds isolated from Colombian plants. | 2004 Mar |
|
Cholesterol-sensor initiates M. tuberculosis entry into human macrophages. | 2004 Mar |
|
Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA. | 2004 Mar |
|
Conformational changes in the Arp2/3 complex leading to actin nucleation. | 2005 Jan |
|
Dynamic properties of Legionella-containing phagosomes in Dictyostelium amoebae. | 2005 Jul |
|
A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. | 2005 Oct |
|
Phosphorylation of coronin 1B by protein kinase C regulates interaction with Arp2/3 and cell motility. | 2005 Sep 9 |
|
Green tea polyphenol inhibits Mycobacterium tuberculosis survival within human macrophages. | 2006 |
|
Effusion and solid lymphomas have distinctive gene and protein expression profiles in an animal model of primary effusion lymphoma. | 2006 Aug |
|
Requirement for coronin 1 in T lymphocyte trafficking and cellular homeostasis. | 2006 Aug 11 |
|
Transcriptional regulation of artemin is related to neurite outgrowth and actin polymerization in mature DRG neurons. | 2006 Aug 14 |
|
Time-resolved responses to chemoattractant, characteristic of the front and tail of Dictyostelium cells. | 2006 Dec 11 |
|
The identification of a new actin-binding region in p57. | 2006 Jan |
|
The crystal structure of murine coronin-1: a regulator of actin cytoskeletal dynamics in lymphocytes. | 2006 Jan |
|
Ultraviolet photoionization of the photosensitizers khellin and visnagin in aqueous solution and in micelles: one-photon ionization is a minor process. | 2006 Mar |
|
Microtubules regulate disassembly of epithelial apical junctions. | 2006 Mar 1 |
|
The embryonic muscle transcriptome of Caenorhabditis elegans. | 2007 |
|
Global gene expression analysis and regulation of the principal genes expressed in bovine placenta in relation to the transcription factor AP-2 family. | 2007 Apr 27 |
|
Survival of mycobacteria in macrophages is mediated by coronin 1-dependent activation of calcineurin. | 2007 Jul 13 |
|
Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate. | 2007 Jun |
|
Coronin function is required for chemotaxis and phagocytosis in human neutrophils. | 2007 May 1 |
|
STATc is a key regulator of the transcriptional response to hyperosmotic shock. | 2007 May 21 |
|
Gene expression profiles in testis of pigs with extreme high and low levels of androstenone. | 2007 Nov 7 |
|
Functional analysis of cancer-associated EGFR mutants using a cellular assay with YFP-tagged EGFR intracellular domain. | 2007 Sep 18 |
|
Coronin-1A stabilizes F-actin by bridging adjacent actin protomers and stapling opposite strands of the actin filament. | 2008 Feb 22 |
|
The lupus-related Lmb3 locus contains a disease-suppressing Coronin-1A gene mutation. | 2008 Jan |
|
Coronin-1A epigenomics governs mycobacterial persistence in tuberculosis. | 2008 Jan |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/npp/khella.html
Oral: 200 mg/day
Topical: as a 2% preparation
Route of Administration:
Other
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/3283251
In neutral O2-saturated aqueous solution, the photosensitized His degradation quantum yield is about 8x10(-5) for khellin. In O2-saturated aqueous solution, khellin photosensitized the oxidation of Trp with a quantum yield of 1.5x10(-4), which is quite low.
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C45597
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
37744
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
25509
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
M6626
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB08380MIG
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
C75957
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
5G117T0TJZ
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
201-392-8
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
82-02-0
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
6147
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | RxNorm | ||
|
192
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
D007666
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
3828
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
DTXSID9045267
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
CHEMBL44746
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
KHELLIN
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
6133
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
100000083079
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY | |||
|
3313
Created by
admin on Wed Jul 05 22:58:54 UTC 2023 , Edited by admin on Wed Jul 05 22:58:54 UTC 2023
|
PRIMARY |
ACTIVE MOIETY